We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock)

First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening

A cost-effectiveness analysis has revealed that using biparametric MRI as an initial screening tool is less cost-effective than the traditional approach of first-line PSA testing followed by multiparametric MRI. More...
12 Jun 2024
Image: The Olink Explore platform can identify proteins in blood that may provide a 7-year warning for various cancers (Photo courtesy of Olink Holding)

Proteomics Platform Identifies Proteins in Blood to Give Cancer Warning 7 Years before Diagnosis

Researchers have employed a cutting-edge proteomics platform to identify blood proteins that could potentially provide a seven-year advance warning for various types of cancer. More...
11 Jun 2024
Image: Illustration representing DELFI approach for lung cancer detection (Photo courtesy of Cancer Discovery)

AI Technology-Based Blood Test Identifies Lung Cancer Earlier

Researchers have leveraged AI to spot patterns of DNA fragments linked to lung cancer, which has led to the development and validation of a liquid biopsy that could identify the disease earlier. More...
10 Jun 2024
Image: The ultra-sensitive blood test detects tiny amounts of cancer DNA left in the body after treatment for early breast cancer (Photo courtesy of ICR)

Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Months or Even Years before Relapse

A new type of blood test can predict breast cancer recurrence in high-risk patients who have undergone surgery or other treatments months or even years before relapse occurs. More...
07 Jun 2024
Image: Prenatal testing offers a window for finding a mother’s cancer risk (Photo courtesy of Shutterstock)

Prenatal Testing Offers Window for Finding Mother’s Cancer Risk

The inclusion of BRCA1 testing during obstetrical prenatal carrier screening has been found to be cost-effective and capable of identifying at-risk individuals at a critical time when preventative strategies could be lifesaving. More...
07 Jun 2024
Image: Microscopic view of the HPV human papillomavirus that causes cervical cancer (credit: Adobe Stock Images)

New Molecular Test Detects More Cervical Cancer Cases

Researchers have developed a simpler and more effective screening method for cervical cancer than the current one that has the potential to replace cytological analysis. More...
06 Jun 2024
Image: The QIAstat-Dx Gastrointestinal Panel 2 has received U.S. FDA clearance for use in clinical settings (Photo courtesy of QIAGEN)

New Panel Quickly and Accurately Identifies 16 Common Gastrointestinal Pathogens

An innovative molecular test offers rapid and accurate identification of up to 16 common gastrointestinal pathogens, generating results in approximately one hour using real-time PCR technology. More...
06 Jun 2024
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Laboratory Software
ArtelWare
New
Gold Member
Hematology Analyzer
Medonic M32B


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.